Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats

British Journal of Pharmacology

Volumn 159, Issue 4, 2010, Pages 958-969

  Lam, Francis F Y ^a   Ng, Ethel S K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adjuvant induced arthritis; AP7; CNQX; Dexamethasone; Glutamate; RP67580; Substance P

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DEXAMETHASONE; FREUND ADJUVANT; GLUTAMATE RECEPTOR ANTAGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P ANTAGONIST;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HYPEREMIA; JOINT SWELLING; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIUM;

2-AMINO-5-PHOSPHONOVALERATE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; DEXAMETHASONE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FREUND'S ADJUVANT; GLUTAMIC ACID; INJECTIONS, INTRA-ARTICULAR; ISOINDOLES; KNEE JOINT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; RECEPTORS, NEUROKININ-1; SUBSTANCE P; TIME FACTORS;

EID: 77249118278     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00586.x     Document Type: Article

References (59)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Arend WP (1997). The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum 40 : 595 597.
3. Baeuerle PA, Henkel T (1994). Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 : 141 179.
4. Battaglia G, Rustioni A (1988). Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurol 277 : 302 312.
5. Bendele AM (2001). Animal models of rheumatoid arthritis. J Musculoskelet Neuron Interact 1 : 377 385.
6. Burcher E, Mussap CJ, Geraghty DP, McClure-Sharp JM, Watkins DJ (1991). Concepts in characterization of tachykinin receptors. Ann N Y Acad Sci 632 : 123 136.
7. Butler RC, Davie MWJ, Worsfold M, Sharp CA (1991). Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Br J Rheumatol 30 : 86 90.
8. Coggeshall RE, Carlton SM (1998). Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery. J Comp Neurol 391 : 78 86.
9. Dayer J-M, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA (1986). Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77 : 645 648.
10. Donaldson LF, Seckl JR, McQueen DS (1993). A discrete adjuvant-induced monoarthritis in the rat: effect of adjuvant dose. J Neurosci Methods 49 : 5 10.
11. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D et al. (2008). Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372 : 375 382.
12. Emery P, Fleischmann RM, Moreland LW, Hsia EC, Strusberg I, Durez P et al. (2009). Golimumab, a human anti-tumor necrosis factor monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naïve patients with active rheumatopid arthritis. Arthritis Rheum 60 : 2271 2283.
13. Feldmann M, Brennan FM, Maini RN (1996). Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 14 : 397 440.
14. Ferrell WR, Lam FY (1996). Sensory neuropeptides in arthritis. In : Geppetti P, Holzer P (eds). Neurogenic Inflammation. CRC Press : Boca Raton, FL, pp. 211 227.
15. Flood S, Parri R, Williams A, Duance V, Mason D (2007). Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors. Arthritis Rheum 56 : 2523 2534.
16. Goudet C, Chapuy E, Alloui A, Acher F, Pin JP, Eschalier A (2008). Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain. Pain 137 : 112 114.
17. Hegen M, Keith JC, Collins M, Nickerson-Nutter CL (2008). Utility of animal models for identitfication of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 67 : 1505 1515.
18. 1 (substance P) receptor antagonists - why are they not analgesic in humans? Trends Pharmacol Sci 21 : 244 246.
19. Hong SK, Han JS, Min SS, Hwang JM, Kim YI, Na HS et al. (2002). Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat. Neurosci Lett 322 : 21 24.
20. Jean YH, Wen ZH, Chang YC, Huang GS, Lee HS, Hsieh SP et al. (2005). Increased concentrations of neuron-excitatory amino acids in rat anteriror cruciate ligament-transected knee joint dialysates: a microdialysis study. J Orthop Res 23 : 569 575.
21. Kimball ES, Perisco FJ, Vaught JL (1988). Substance P, neurokinin A and neurokinin B induce generation of IL-1-like activity in P338D1 cells. J Immun 141 : 3564 3569.
22. Kohara A, Nagakura Y, Kiso T, Toya T, Watabiki T, Tamura S et al. (2007). Antinociceptive profile of a selective metabrotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models. Eur J Pharmacol 571 : 8 16.
23. Laganà B, Vinciguerra M, D'Amelio R (2009). Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatcept. Clin Drug Investig 29 : 185 202.
24. Lam FFY, Wong HHL, Ng ESK (2004). Time course and substance P effects on the vascular and morphological changes in adjuvant-induced monoarthritic rats. Int Immunopharmacol 4 : 299 310.
25. Lam FFY, Ko IWM, Ng ESK, Tam LS, Leung PC, Li EKM (2008). Analgesic and anti-arthritic effects of Lingzhi and San Miao San supplementation in a rat model of arthritis induced by Freund's complete adjuvant. J Ethnopharmacol 120 : 44 50.
26. Lam FY, Ferrell WR (1989a). Capsaicin suppresses substance P-induced joint inflammation in the rat. Neurosci Lett 105 : 155 158.
27. Lam FY, Ferrell WR (1989b). Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis 48 : 928 932.
28. Lam FY, Ferrell WR (1990). Mediators of substance P-induced inflammation in the rat knee joint. Agents Actions 31 : 298 307.
29. Lam FY, Ferrell WR (1991a). Neurogenic component of different models of acute inflammation in the rat knee joint. Ann Rheum Dis 50 : 747 751.
30. Lam FY, Ferrell WR (1991b). Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br J Pharmacol 103 : 1263 1267.
31. Lam FY, Ferrell WR (1993). Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilation assessed by laser doppler perfusion imaging. Neuroscience 52 : 443 449.
32. Lam FY, Wong MC (1996). Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat. Br J Pharmacol 118 : 2107 2114.
33. Lam FY, Ferrell WR, Scott DT (1993). Substance P-induced inflammation in the rat knee joint is mediated by neurokinin 1 (NK1) receptors. Regul Pept 46 : 198 201.
34. Lawand NB, Willis WD, Westlund KN (1997). Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur J Pharmacol 324 : 169 177.
35. Lawand NB, McNearney YT, Westlund KN (2000). Amino acid release into the knee joint: key role in nociception and inflammation. Pain 86 : 69 74.
36. Levine T, Moskowitz MA, Basbaum AI (1985). The contribution of neurogenic inflammation in experimental arthritis. J Immunol 135 : 843s 847s.
37. Lipsky PE, Davis LS, Cush JJ, Oppenheimer-Marks N (1989). The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol 11 : 123 162.
38. Lotz M, Carson DA, Vaught JL (1987). Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235 : 893 896.
39. McNearney YT, Speegle D, Lawand N, Lisse J, Westlund KN (2000). Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 27 : 739 745.
40. McNearney YT, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN (2004). Excitatory amino acids, TNF-, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 137 : 621 627.
41. Majithia V, Geraci SA (2007). Rheumatoid arthritis: diagnosis and management. Am J Med 120 : 936 939.
42. Mazurek N, Pecht I, Teichbury VI, Blumbery S (1981). The role of the N-terminal tetrapeptide in the histamine-releasing action of substance P. Neuropharmacol 20 : 1025 1027.
43. Millan MJ (1999). The induction of pain: an integrative review. Prog Neurobiol 57 : 1 164.
44. Nagasawa H, Takeuchi T (2009). Effect of the inhibition of joint destruction in RA by TNF-blocking agents. Clin Calcium 19 : 416 424.
45. Neugebauer V, Lucke T, Schaible HG (1993). N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiol 70 : 1365 1377.
46. Neveu PJ, Le Moal M (1990). Physiological basis for neuroimmunomodulation. Fundam Clin Pharmacol 4 : 281 305.
47. Omote K, Kawamata T, Kawamata M, Namiki A (1998). Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw. Brain Res 787 : 161 164.
48. Phadke K, Fouts RL, Parrish JE, Butler LD (1985). Evaulation of the effects of various anti-arthritic drugs on Type II collagen-induced mouse arthritic model. Immunopharmacol 10 : 51 60.
49. Roll P, Tony HP (2009). Anti-CD20 in rheumatoid arthritis. Z Rheumatol 68 : 370 379.
50. Schacke H, Docke WD, Asadullah K (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96 : 23 43.
51. Scott DT, Lam FY, Ferrell WR (1991). Time course of substance P-induced protein extravasation in the rat knee joint measured by micro-turbidimetry. Neurosci Lett 129 : 74 76.
52. Scott DT, Lam FY, Ferrell WR (1992). Acute inflammation enhances substance P-induced plasma protein extravasation in the rat knee joint. Regul Pept 39 : 227 235.
53. Scott DT, Lam FY, Ferrell WR (1994). Acute joint inflammation - mechanisms and mediators. Gen Pharmacol 25 : 1285 1296.
54. Sluka KA, Jordan HH, Westlund KN (1994). Reduction in joint swelling and hyperalgesia following post-treatment with a non-NMDA glutamate receptor antagonist. Pain 59 : 95 100.
55. Tsao PW, Susuki T, Totsuka R, Murata T, Takagi T, Ohmachi Y et al. (1997). The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis. Clin Immunol Immunopathol 83 : 173 178.
56. Walker K, Reeve A, Bowes M, Winter J, Wotherspoon G, Davis A et al. (2001). mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology 40 : 10 19.
57. Willetts J, Balster RL, Leander JD (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11 : 423 428.
58. Yu YC, Koo ST, Kim CH, Lyu Y, Grady JJ, Chung JM (2002). Two variables that can be used as pain indices in experimental animal models of arthritis. J Neurosci Methods 115 : 107 113.
59. Zhang GH, Yoon YW, Lee KS, Min SS, Hong SK, Park JY et al. (2003). The glutamatergic N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the joint contribute to the induction, but not maintenance, of arthritic pain in rats. Neurosci Lett 351 : 177 180.